newsfilter
← Latest News
Business Wire·

Delcath Systems Announces Publication of CHOPIN Clinical Trial Results in The Lancet Oncology

Publication Highlights Promise of Combined Percutaneous Hepatic Perfusion and Immunotherapy in Metastatic Uveal Melanoma Delcath Systems, Inc. (NASDAQ:DCTH), ("Delcath" or the "Company") an interventional oncology